Nitric oxide synthase inhibitors for septic shock

Seminars in Pediatric Infectious Diseases

Volumn 12, Issue 1, 2001, Pages 42-45

  Wearden, Mary E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; CANAVANINE; GUANYLATE CYCLASE INHIBITOR; METHYLENE BLUE; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; THIOUREA DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITOR INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; MULTICENTER STUDY; NONHUMAN; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEPTIC SHOCK; VASOMOTOR REFLEX;

EID: 0035139050     PISSN: 10451870     EISSN: None     Source Type: Journal    
DOI: 10.1053/spid.2001.19234     Document Type: Article

References (57)

1. The nitric oxide synthase family of proteins
2. Endothelium and control of vascular function. State of the art
3. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions
4. Nitric oxide synthascs: Roles, tolls and controls
5. Nitric oxide in the nervous system
6. Nitrate synthesis in the germ free and conventional rat
7. Immunochemical localization of inducible nitric oxide synthasc in endotoxintreated rats
8. Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide
9. The high output nitric oxide pathway: Role and regulation
10. Septic shock: Pathogenesis
11. Nitric oxide as a secretory product of mammalian cells
12. Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin
13. Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide
14. Nitric oxide release accounts for the biological activity of cndothelium-derived relaxing factor
15. Differential effects of monoclonal antibodies to tumor necrosis Factor alpha and gamma interferon on induction of hepatic nitric oxide synthase in experimental gram negative sepsis
16. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells
17. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat
18. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is a tetrahydrobiopterin-dependent, calmodulin-lndepcndent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages
19. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo
20. Protective and pathological roles of nitric oxide in endotoxic shock
21. The role of nitric oxide in endotoxic shock: Effects of NG-monomethyl-L-arginine
22. Inhibition of nitric oxide synthase in experimental gram-negative sepsis
23. N-Omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canine challenged with endotoxin
24. Beneficial effects and improved survival in rodent models of septic shock with Smethylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase
25. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
26. Altered immune responses in mice lacking inducible nitric oxide synthase
27. Nitrogen oxide levels in patients after trauma and during sepsis
28. Inhibition of nitric oxide synthase in experimental gram-negative sepsis
29. Plasma nitric oxide levels in newborn infants with sepsis
30. Increased serum nitrite and nitrate concentrations in children with sepsis syndrome
31. Nitric oxide production in critically ill patients
32. Inflammatory cytokine and nitric oxide response in pediatric sepsis and organ failure
33. Plasma nitrite and nitrate concentrntions and multiple organ failure in pediatric sepsis
34. Activation of the L-arginine nitric oxide pathway in severe sepsis
35. Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock
36. Nitric oxide production in meningococcal disease is directly related to disease severity
37. Age related changes of urinary nitrite/nitrate excretion in normal children
38. Urinary nitrite/nitrate excretion in infancy: Comparison between term and preterm infants
39. Sources of nitrates and nitrites in neonates with sepsis
40. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock
41. G-mono methyl-L-arginine, an inhibitor of the nitric oxide synthetase
42. Effects of a nitric oxide synthase inhibitor in humans with septic shock
43. L-arginine patbway in the sepsis syndrome
44. Stimulation of T cell immunity by arginine enhances survival in peritonitis
45. Arginine-supplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance. The role of nitric oxide
46. An open-label dose escalation study of the nitric oxide synthase inhibitor, NG-methyl-L-arginine hydrochloride (546C88), in patients with septic shock
47. The nitric oxide synthase inhibitor 546C88 promotes the resolution of shock in patients with severe sepsis
48. Hemodynamic support in fluid-refractory pediatric septic shock
49. A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: Comparison with two nonselective strategies
50. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock
51. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock
52. Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations
53. Methylene blue administration in septic shock: A clinical trial
54. Effect of methylene blue on refractory neonatal hypotension
55. Inhibition of nitric oxide synthesis by methylene blue
56. Effect of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase
57. Modulating the L-arginine-nitric oxide pathway in septic shock: Choosing the proper point of attack